Opus Historical Income Statement
| IRD Stock | 1.11 0.06 5.71% |
Historical analysis of Opus Genetics, income statement accounts such as Selling General Administrative of 8.3 M or Total Revenue of 16.4 M can show how well Opus Genetics, performed in making a profits. Evaluating Opus Genetics, income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Opus Genetics,'s future profits or losses.
Opus Genetics, Net Income |
|
Opus |
About Opus Income Statement Analysis
Opus Genetics, Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Opus Genetics, shareholders. The income statement also shows Opus investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Opus Genetics, Income Statement Chart
Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Opus Genetics, financial statement analysis. It represents the amount of money remaining after all of Opus Genetics, operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Opus Genetics,'s income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Opus Genetics, current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Opus Genetics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.The current year's Total Other Income Expense Net is expected to grow to about 2 M, whereas Net Interest Income is forecasted to decline to (1.4 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 23.3M | 21.6M | 29.6M | 23.1M | Research Development | 15.2M | 14.4M | 17.7M | 14.8M |
Opus Genetics, income statement Correlations
Click cells to compare fundamentals
Opus Genetics, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Opus Genetics, is a strong investment it is important to analyze Opus Genetics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Opus Genetics,'s future performance. For an informed investment choice regarding Opus Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Opus Genetics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opus Genetics,. If investors know Opus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opus Genetics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opus Genetics, is measured differently than its book value, which is the value of Opus that is recorded on the company's balance sheet. Investors also form their own opinion of Opus Genetics,'s value that differs from its market value or its book value, called intrinsic value, which is Opus Genetics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opus Genetics,'s market value can be influenced by many factors that don't directly affect Opus Genetics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opus Genetics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Opus Genetics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opus Genetics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.